KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Return on Equity (2018 - 2025)

Twist Bioscience (TWST) has disclosed Return on Equity for 6 consecutive years, with 0.31% as the latest value for Q2 2023.

  • On a quarterly basis, Return on Equity fell 6.0% to 0.31% in Q2 2023 year-over-year; TTM through Jun 2023 was 0.31%, a 6.0% decrease, with the full-year FY2022 number at 0.32%, up 1.0% from a year prior.
  • Return on Equity was 0.31% for Q2 2023 at Twist Bioscience, down from 0.29% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.2% in Q1 2021 to a low of 1.11% in Q4 2019.
  • A 5-year average of 0.42% and a median of 0.29% in 2022 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: plummeted -301bps in 2019, then skyrocketed 87bps in 2020.
  • Twist Bioscience's Return on Equity stood at 1.11% in 2019, then skyrocketed by 78bps to 0.24% in 2020, then dropped by -13bps to 0.27% in 2021, then decreased by -2bps to 0.28% in 2022, then dropped by -10bps to 0.31% in 2023.
  • Per Business Quant, the three most recent readings for TWST's Return on Equity are 0.31% (Q2 2023), 0.29% (Q1 2023), and 0.28% (Q4 2022).